Analysts’ Weekly Ratings Updates for Astera Labs (ALAB)

A number of research firms have changed their ratings and price targets for Astera Labs (NASDAQ: ALAB):

• 12/9/2025 – Astera Labs had its price target raised by analysts at Northland Securities from $175.00 to $195.00. They now have an “outperform” rating on the stock.
• 12/9/2025 – Astera Labs had its “outperform” rating reaffirmed by analysts at Citigroup Inc..
• 12/3/2025 – Astera Labs had its “overweight” rating reaffirmed by analysts at Morgan Stanley. They now have a $210.00 price target on the stock.
• 12/3/2025 – Astera Labs had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc..
• 11/21/2025 – Astera Labs is now covered by analysts at Raymond James Financial, Inc.. They set a “hold” rating on the stock.
• 11/20/2025 – Astera Labs is now covered by analysts at BNP Paribas. They set an “outperform” rating on the stock.
• 11/20/2025 – Astera Labs is now covered by analysts at BNP Paribas Exane. They set an “outperform” rating and a $225.00 price target on the stock.
• 11/17/2025 – Astera Labs was given a new $175.00 price target on by analysts at Northland Securities.
• 11/17/2025 – Astera Labs was upgraded by analysts at Northland Capmk from a “hold” rating to a “strong-buy” rating.
• 11/17/2025 – Astera Labs was upgraded by analysts at Northland Securities from a “market perform” rating to an “outperform” rating. They now have a $175.00 price target on the stock.
• 11/11/2025 – Astera Labs was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 11/5/2025 – Astera Labs had its “hold” rating reaffirmed by analysts at Cowen Inc.
• 11/5/2025 – Astera Labs had its price target raised by analysts at Needham & Company LLC from $205.00 to $220.00. They now have a “buy” rating on the stock.
• 11/5/2025 – Astera Labs had its price target raised by analysts at Morgan Stanley from $200.00 to $210.00. They now have an “overweight” rating on the stock.
• 11/5/2025 – Astera Labs had its price target raised by analysts at Roth Capital from $200.00 to $225.00. They now have a “buy” rating on the stock.
• 11/5/2025 – Astera Labs had its price target raised by analysts at JPMorgan Chase & Co. from $180.00 to $215.00. They now have an “overweight” rating on the stock.
• 11/5/2025 – Astera Labs had its price target raised by analysts at Stifel Nicolaus from $185.00 to $200.00. They now have a “buy” rating on the stock.
• 11/5/2025 – Astera Labs had its price target lowered by analysts at TD Cowen from $225.00 to $170.00. They now have a “hold” rating on the stock.
• 11/3/2025 – Astera Labs was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 10/26/2025 – Astera Labs was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 10/20/2025 – Astera Labs had its “equal weight” rating reaffirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock.
• 10/18/2025 – Astera Labs was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 10/17/2025 – Astera Labs had its price target raised by analysts at Stifel Nicolaus from $174.00 to $185.00. They now have a “buy” rating on the stock.

Insider Buying and Selling

In other Astera Labs news, CEO Jitendra Mohan sold 90,459 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the sale, the chief executive officer directly owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. The trade was a 4.17% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $166.18, for a total value of $24,927,000.00. Following the completion of the transaction, the director owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This trade represents a 8.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 586,936 shares of company stock worth $89,331,140 in the last quarter. 12.50% of the stock is owned by insiders.

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.